Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Bios Capital Management, Lp > Profile

Instuitional Investor - Bios Capital Management, Lp

Fund Profile
Filing Period:
Fund Name: Bios Capital Management, Lp
Portfolio Value $72,575,243
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Actuate Therapeutics Inc
 9,965,079 $60,886,633 83.89%
2.
Opus Genetics Inc
 3,683,429 $3,462,423 4.77%
3.
Lantern Pharma Inc.
 LTRN 1,075,952 $3,400,008 4.68%
4.
Rein Therapeutics Inc.
 RNTX 1,690,751 $2,367,051 3.26%
5.
Cognition Therapeutics Inc
 CGTX 6,000,000 $1,860,000 2.56%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)